IP Library Granted Patent US 11,945,955
Granted Patent B2
US 11,945,955 · App. 17/735,947 · Granted Apr 2, 2024

Polymeric tandem dyes with linker groups

Inventors: Tracy Matray (Snohomish, WA); Michael Vanbrunt (Covington, WA)
Assignee: SONY GROUP CORPORATION
C09B69/10C07F9/098C07F9/65586G01N21/6428G01N33/582G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,945,955
App. No.
17/735,947
Granted
Apr 2, 2024
Kind
B2
Abstract

Compounds useful as fluorescent or colored dyes are disclosed. In some embodiments, the compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , L 1 , L 2 , L 3 , L 4 , M 1 , M 2 , m, and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.

Claims (47)

1. A compound having the following structure (I):

or a stereoisomer, salt, or tautomer thereof, wherein:

M 1 and M 2 are, at each occurrence, independently a chromophore, provided that at least one of M 1 and M 2 is a FRET donor, and another one of M 1 and M 2 is a corresponding FRET acceptor, and at least one occurrence a FRET donor is positioned between two FRET acceptors;

L 1 is, at each occurrence, an optional linker, provided that at least one occurrence of L 1 is present and comprises oxygen, wherein at least one occurrence of L′ is a linker comprising a triazolyl functional group;

L 2 and L 3 are, at each occurrence, independently an optional alkylene, alkenylene, alkynylene, heteroalkylene, heteroalkenylene, heteroalkynylene or heteroatomic linker;

L 4 is, at each occurrence, independently an alkylene or heteroalkylene linker;

R 1 is, at each occurrence, independently H, alkyl or alkoxy;

R 2 and R 3 are each independently H, OH, SH, alkyl, alkoxy, alkylether, heteroalkyl, —OP(═R a )(R b )R c , Q, or a protected form thereof, or L′;

R 4 is, at each occurrence, independently OH, SH, O − , S − , OR d or SR d ;

R 5 is, at each occurrence, independently oxo, thioxo or absent;

R a is O or S;

R b is OH, SH, O − , S − , OR d or SR d ;

R c is OH, SH, O − , S − , OR d , OL′, SR d , alkyl, alkoxy, heteroalkyl, heteroalkoxy, alkylether, alkoxyalkylether, phosphate, thiophosphate, phosphoalkyl, thiophosphoalkyl, phosphoalkylether or thiophosphoalkylether;

R d is a counter ion;

Q is, at each occurrence, independently a moiety comprising a reactive group, or protected form thereof, capable of forming a covalent bond with an analyte molecule, a targeting moiety, a solid support, or a complementary reactive group Q;

L′ is, at each occurrence, independently a linker comprising a covalent bond to Q, a linker comprising a covalent bond to a targeting moiety, a linker comprising a covalent bond to an analyte molecule, a linker comprising a covalent bond to a solid support, a linker comprising a covalent bond to a solid support residue, a linker comprising a covalent bond to a nucleoside or a linker comprising a covalent bond to a further compound of structure (I);

m is, at each occurrence, independently an integer of zero or greater; and

n is an integer of two or greater.

2. The compound of claim 1 , wherein the compound has the following structure (IA):

wherein:

z is, at each occurrence, independently an integer from 1 to 100; and

m is, at each occurrence, independently an integer from 0 to 6.

3. The compound of claim 2 , wherein z is, at each occurrence, independently an integer from 1 to 30.

4. The compound of claim 2 , wherein m is, at each occurrence, independently an integer from 2-4.

5. The compound of claim 2 , wherein the compound has the following structure (IB):

wherein:

x 1 , x 2 , x 3 , and x 4 are, at each occurrence, independently an integer from 0 to 6.

6. The compound of claim 1 , wherein at least one occurrence of L 1 -M 1 or L 1 -M 2 comprises one of the following structures:

wherein L a and L b are each independently optional linkers.

7. The compound of claim 6 , wherein L a or L b , or both, is absent.

8. The compound of claim 6 , wherein L a or L b , or both, is present.

9. The compound of claim 8 , wherein L a and L b , when present, are each independently alkylene or heteroalkylene.

10. The compound of claim 8 , wherein L a and L b independently have one of the following structures:

11. The compound of claim 1 , wherein R 4 is, at each occurrence, independently OH, O − or OR d ; R 5 is, at each occurrence, oxo; and R 1 is, at each occurrence, H.

12. The compound of claim 1 , wherein one of R 2 or R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 or R 3 is Q or a linker comprising a covalent bond to Q.

13. The compound of claim 1 , wherein Q has one of the following structures:

wherein each X is independently a halogen.

14. The compound of claim 1 , wherein one of R 2 or R 3 is OH or —OP(═R a )(R b )R c , and the other of R 2 or R 3 is a linker comprising a covalent bond to an analyte molecule or a linker comprising a covalent bond to a solid support.

15. The compound of claim 1 , wherein R 2 or R 3 has one of the following structures:

16. The compound of claim 1 , wherein at least one combination of M 1 and M 2 is a FRET pair with a J-value greater than about 1×10 10 .

17. The compound of claim 1 , wherein M 1 and M 2 are, at each occurrence, independently selected from the group consisting of:

i) a dimethylaminostilbene, quinacridone, fluorophenyl-dimethyl-BODIPY, his-fluorophenyl-BODIPY, acridine, terrylene, sexiphenyl, porphyrin, benzopyrene, (fluorophenyl-dimethyl-difluorobora-diaza-indacene)phenyl, (bis-fluorophenyl-difluorobora-diaza-indacene)phenyl, quaterphenyl, bi-benzothiazole, ter-benzothiazole, bi-naphthyl, bi-anthracyl, squaraine, squarylium, 9,10-ethynylanthracene, and ter-naphthyl moiety;

ii) p-terphenyl, perylene, azobenzene, phenazine, phenanthroline, acridine, thioxanthrene, chrysene, rubrene, coronene, cyanine, perylene imide, perylene amide, and derivatives thereof;

iii) a coumarin dye, resorufin dye, dipyrrometheneboron difluoride dye, ruthenium bipyridyl dye, thiazole orange dye, polymethine, and N-aryl-1,8-naphthalimide dye; or

iv) a coumarin dye, boron-dipyrromethene, rhodamine, cyanine, pyrene, perylene, perylene monoimide, 6-FAM, 5-FAM, 6-FITC, 5-FITC, and derivatives thereof.

18. The compound of claim 1 , wherein M 1 and M 2 form a FRET pair, wherein M 1 and M 2 at each occurrence, independently have one of the following structures:

19. A composition comprising the compound of claim 1 and one or more analyte molecules.

Continuity (4)
Division 17242106 · Apr 27, 2021
Continuation PCTUS2020052754 · Sep 25, 2020
Provisional Application 62906591 · Sep 26, 2019
Related Publication 20220380603A1 · Dec 1, 2022
Cited By (14)
US 12,270,812 US 12,275,851 US 12,290,571 US 12,319,817 US 12,359,071 US 12,391,833 US 12,461,106 US 12,473,433 US 12,539,334 US 12,560,612 US 12,577,403 US 12,578,342 US 12,606,588 US 12,629,425